AI Verdict
HRMY has stronger fundamentals based on our AI analysis.
HSCT vs HRMY Fundamental Comparison
| Metric | HSCT | HRMY |
|---|---|---|
| Revenue | $0.0 | $868.5M |
| Net Income | $-33,021.0 | $158.7M |
| Net Margin | N/A | 18.3% |
| ROE | N/A | 18.2% |
| ROA | -42.9% | 12.5% |
| Current Ratio | 0.28x | 3.60x |
| Debt/Equity | N/A | 0.19x |
| EPS | $0.00 | $2.71 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
HSCT vs HRMY: Frequently Asked Questions
Is HSCT or HRMY a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), HRMY has stronger fundamentals. HSCT is rated STRONG SELL (98% confidence) while HRMY is rated BUY (78% confidence). This is not investment advice.
How does HSCT compare to HRMY fundamentally?
HOOPS SCOUTING USA has ROE of N/A vs Harmony Biosciences Holdings, Inc.'s 18.2%. Net margins are N/A vs 18.3% respectively.
Which stock pays higher dividends, HSCT or HRMY?
HSCT has a dividend yield of N/A or no dividend while HRMY has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in HSCT or HRMY for long term?
For long-term investing, consider that HSCT has STRONG SELL rating with 98% confidence, while HRMY has BUY rating with 78% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about HSCT vs HRMY?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For HSCT vs HRMY, the AI consensus favors HRMY based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.